In the study, scientists at the University of Michigan treated mice that had breast cancer with Avastin and Sutent (chemical names bevacizumab and sunitinib). The drugs stop new blood vessels forming, a process called angiogenesis, so that the supply of food and oxygen to the tumour is reduced.
|PNAS | 23 January 2012|
|CBS News | 26 January 2012|
|EurekAlert! | 25 January 2012|
|NEJM | 26 January 2012|
|Medical News Today | 26 January 2012|
|Med Page Today | 26 January 2012|